14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.30 $3.29 Thursday, 25th Apr 2024 ABUS stock ended at $2.72. This is 1.09% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.43% from a day low at $2.68 to a day high of $2.75.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
Dec 04, 2020 $3.98 $4.06 $3.78 $4.01 2 133 285
Dec 03, 2020 $4.03 $4.09 $3.91 $3.94 2 118 197
Dec 02, 2020 $4.08 $4.10 $3.88 $3.95 3 092 894
Dec 01, 2020 $4.84 $4.90 $3.99 $3.99 6 459 042
Nov 30, 2020 $4.89 $4.90 $4.32 $4.53 5 595 305
Nov 27, 2020 $4.00 $4.56 $3.95 $4.34 5 291 347
Nov 25, 2020 $3.61 $3.87 $3.61 $3.77 1 783 322
Nov 24, 2020 $3.70 $3.87 $3.50 $3.59 2 039 277
Nov 23, 2020 $3.44 $3.74 $3.41 $3.67 3 009 872
Nov 20, 2020 $3.36 $3.41 $3.32 $3.36 765 244
Nov 19, 2020 $3.43 $3.46 $3.23 $3.34 1 371 852
Nov 18, 2020 $3.60 $3.68 $3.36 $3.39 1 714 596
Nov 17, 2020 $3.63 $3.70 $3.41 $3.61 1 858 933
Nov 16, 2020 $3.98 $4.14 $3.57 $3.63 6 206 576
Nov 13, 2020 $3.56 $3.69 $3.42 $3.63 1 805 023
Nov 12, 2020 $3.62 $3.75 $3.43 $3.55 2 151 714
Nov 11, 2020 $3.27 $3.59 $3.21 $3.57 2 369 941
Nov 10, 2020 $3.30 $3.31 $3.08 $3.24 1 501 609
Nov 09, 2020 $2.98 $3.38 $2.90 $3.18 3 374 010
Nov 06, 2020 $2.84 $2.87 $2.76 $2.79 1 279 289
Nov 05, 2020 $2.87 $3.05 $2.80 $2.87 1 599 636
Nov 04, 2020 $2.90 $3.09 $2.87 $3.06 923 609
Nov 03, 2020 $2.76 $2.91 $2.76 $2.89 574 309
Nov 02, 2020 $2.84 $2.85 $2.72 $2.76 957 187
Oct 30, 2020 $2.92 $2.94 $2.77 $2.82 723 964
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT